Royal Philips and Radboud University Medical Center (Nijmegen, Netherlands) have launched a prototype monitoring device to support patients with COPD.
A new clinical study is treating COPD patients with an investigational procedure called Targeted Lung Denervation, which results in smooth muscle relaxation throughout the lungs.
COPD patients reported improved symptoms and health status when they use a hand-held respiratory device called the Lung Flute, according to University of Buffalo study.
After 3 weeks of daily use, the Aerobika Oscillating Positive Expiratory Pressure (OPEP) device provided statistically significant outcomes in patients with COPD and bronchiectasis.
“Tome Un Respiro” is a Spanish-language campaign to raise awareness among Hispanics in the US about the prevalence, treatment options, and disease management of COPD.
The company’s site says it is approaching chronic inflammatory diseases like asthma and chronic obstructive pulmonary disease by modifying them rather than suppressing systems.
The new website encourages patient interaction and education about COPD.
The FDA has approved Striverdi Respimat (olodaterol) inhalation spray to treat patients with COPD, including chronic bronchitis and/or emphysema that are experiencing airflow obstruction.
An exercise program that increases COPD patients’ ability to perform physical activity with a lessened sensation of dyspnea is a primary goal of rehabilitation.
Obesity, especially excessive belly fat, is a risk factor for COPD, according to an article in the Canadian Medical Association Journal.